US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 24.290
  • -0.640-2.57%
Close May 10 16:00 ET
  • 24.000
  • -0.290-1.19%
Post 19:23 ET
712.90MMarket Cap-8264P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dianthus Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

457.00K

-61.11%
EPS(YoY)

-0.71

-4.42%
Analyst Rating

Strong Buy

May 10, 2024

Dianthus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 376.400K--
--2024/Q2-- / 376.400K--
--2024/Q1874.000K / 371.400K--
--2023/Q4457.000K / 438.800K--
--2023/Q3924.000K / 250.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 376.400K--
--2024/Q2-- / 376.400K--
--2024/Q1874.000K / 371.400K--
--2023/Q4457.000K / 438.800K--
--2023/Q3924.000K / 250.000K--

Dianthus Therapeutics Earnings Reports

  • Dianthus Therapeutics | 10-Q: Quarterly report

    May 9 16:53 ET

  • Dianthus Therapeutics | 10-K: Annual report

    Mar 21 16:14 ET

  • Dianthus Therapeutics | 10-Q: Quarterly report

    Nov 9, 2023 16:15 ET

  • Magenta Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 08:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 10, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg